In patients undergoing a variety of nonneurosurgical operations, smoking has been identified as an independent risk factor for poor perioperative outcomes. 7, 13, 23 In spine surgery there is equivocal evidence of an association between smoking and postoperative outcomes. 18, 20, 24 In cranial neurosurgery the impact of smoking on outcomes has been studied in only limited clinical settings. Smoking is a known risk factor for formation of intracranial aneurysm, 3 subarachnoid hemorrhage (SAH), 9, 10 and symptomatic vasospasm. 14 In patients undergoing craniotomy for tumor resection, Lau et al. 15 reported that smoking increased the risk for morbidity and the 1-year mortality rate. However, the effect of cigarette smoking as a potentially modifiable preoperative risk factor that influences outcomes in patients undergoing elective cranial surgeries is unknown.
Smoking and postoperative outcomes in elective cranial surgery
We used a large, national, prospectively collected database from the National Surgical Quality Improvement Program (NSQIP) to examine whether perioperative smoking in patients undergoing elective cranial surgery influenced 30-day outcomes postoperatively.
Methods

Data Source
We identified patients who underwent elective cranial surgery by using the American College of Surgeons (ACS)-NSQIP database for records obtained between 2006 and 2011. Detailed descriptions of the ACS-NSQIP database can be found elsewhere. 1, 12 The study was approved by the Cleveland Clinic Institutional Review Board.
Patient Population
We used the Current Procedure Terminology (CPT) codes to identify 10,651 patients who were 18 years of age and older, and who underwent cranial surgery between 2006 and 2011. We excluded 2122 emergency cases because smoking cessation intervention would not be possible. We also excluded 233 patients with unknown smoking status. Our final study sample consisted of 8296 patients with known smoking status, who underwent elective cranial surgery.
Smoking Status
We grouped patients according to their smoking status: current, prior, and never smoker. 7, 20 The NSQIP database contains 2 smoking variables: the first is "current smoker," defined as smoking within 1 year prior to surgery and smoking duration as determined by total number of pack years. A current smoker was defined as a patient with "yes" for the NSQIP current-smoker variables and having either a missing value or a value > 0 for pack years. The second is a "prior smoker," defined as having a "no" for the current-smoker variable and a value > 0 for pack years. We defined a "never smoker" as someone having a "no" for the current-smoker variable and a value of 0 or missing for the pack-year variable.
Covariates
Available perioperative factors that may affect postoperative outcome were analyzed (Table 1) .
Postoperative Outcomes
Short-term postoperative complications, defined as occurring within 30 days after surgery, were assessed for each patient group. Prolonged length of stay (LOS) was defined as LOS longer than that of the third quartile of the mean LOS; thus, prolonged LOS was considered to be ≥ 8 days. Minor complications consisted of ≥ 1 of the following: superficial surgical site infection, urinary tract infection, deep venous thrombosis, or thrombophlebitis. Major complications were ≥ 1 of the following: deep incision surgical site infection, organ or space surgical site infection, wound disruption, pneumonia, unplanned intubation, pulmonary embolism, > 48 hour postoperative ventilator-assisted respiration, progressive renal insufficiency, acute renal failure, cardiovascular accident with neurological deficit, coma of > 24 hours, peripheral nerve injury, cardiac arrest requiring cardiopulmonary resuscitation, myocardial infarction, graft, prosthesis or flap failure, sepsis, septic shock, and/or return within 30 days to the operating room (OR). Any complication was defined as ≥ 1 minor or major complication. Thirty-day return to the OR, defined as any unplanned return to the OR for a surgical procedure, and 30-day mortality were also assessed.
Statistical Analyses
Preoperative and intraoperative and 30-day outcomes were compared between smokers (current and prior) and never smokers by using Pearson chi-square tests for categorical variables and ANOVA for continuous variables. Propensity scores, including all variables from Table  1 , were generated to obtain an approximately unbiased measure of the association between smoking and adverse outcomes. 19 A 1:1 greedy matching technique 4 was used first to match prior smokers with a unique never smoker on both propensity score and age, and similarly, current smokers with a unique never smoker. Restrictions were set on the matching criteria to within 0.2 SDs of the propensity score, to allow for increased accuracy in matching.
Covariates were compared between smoking groups in the matched sample. Logistic regression analysis was used to test whether different smoking categories were independently associated with adverse outcomes. Covariates that remained unbalanced after matching based on propensity scores were included in the final models. The relationship between pack years and adverse outcomes was also tested in the entire sample, pooling current and prior smokers and, after matching based on propensity score was performed, separately comparing current with never smokers and prior with never smokers. A p value of < 0.05 was considered statistically significant; SAS (version 9.2, SAS Institute) was used.
Results
Compared with never smokers, current smokers were younger by an average of 4 years, and were more likely to be male and African American (Table 1 ). Daily consumption of > 2 alcoholic beverages was more prevalent among current smokers versus never smokers (4.8% vs 1.3%, p < 0.001), and the former had a slightly lower body mass index ([BMI] 27.6 ± 6.4 vs 28.5 ± 6.5, p < 0.001). Furthermore, current smokers were more likely to have pulmonary (10.7% vs 3.1%, p < 0.001) and CNS (19.1% vs 13.1%, p < 0.001) comorbidities than never smokers. Disseminated cancer was present in 16.8% of current smokers versus 10.0% of never smokers (p < 0.001). However, hypertension (34.9% vs 39.9%, p < 0.001) and diabetes (9.8% vs 11.6%, p = 0.04) were more common among never smokers. Current smokers, compared with never smokers, were more likely to have abnormal albumin (10.9% vs 8.3%, p < 0.001), serum glutamic oxaloacetic Creatinine and blood urea nitrogen (BUN) were also more commonly abnormal among never smokers than current smokers. We compared baseline characteristics between prior and never smokers (Table 1) . Prior smokers were older by an average of 6 years, more likely to be male, and to have a slightly higher BMI. Alcohol consumption of > 2 drinks daily was three times more frequent among prior smokers (3.9%) than in never smokers (1.3%, p < 0.001). Pulmonary (9.7% vs 3.1%, p < 0.001), cardiovascular (12.8% vs 4.7%, p < 0.001), CNS (21.4% vs 13.1%, p < 0.001), and bleeding comorbidities (3.9% vs 2.9%, p = 0.01) were more common in prior smokers. In addition, hypertension, diabetes, and disseminated cancer were more common among prior smokers. Altered laboratory values were similarly frequent among prior and never smokers, except for abnormal BUN (27.2% vs 24.7%, p < 0.001) or creatinine (7.1% vs 4.7%, p = 0.01), which were more likely to be present in prior smokers.
Total LOS reported as median and interquartile range ([IQR] 25%-75%) differed between current (4 days, IQR 3-8 days), prior (3 days, IQR 2-8 days), and never (4 days, IQR 2-8 days) smokers (Table 2) . However, prolonged LOS, postoperative complications, return to OR, and 30-day mortality was similarly frequent among all 3 groups.
Patients were matched based on age and propensity score generated from all other covariates included in this study. We matched 1657 current and never smokers (Table 3) . Current smokers were slightly more likely to consume excessive amounts of alcohol daily (4.1% vs 3.1%, p < 0.001). Pulmonary comorbidities continued to be more common among current (9.1%) than never (6.5%) smokers, p < 0.01. However, preoperative chemo-and/or radiotherapy was more prevalent in never (4.2%) than in current (2.2%) smokers (p < 0.01).
After matching prior and never smokers (n = 833), daily alcohol consumption was slightly more common in the latter (4.2% vs 3.8%, p < 0.001). Never smokers were more likely to be partially or fully dependent (16.7% vs 11.9%, p = 0.01). Pulmonary comorbidities were more prevalent in never (12.1%) than in prior (9%) smokers (p = 0.04). Abnormalities in albumin, BUN, total bilirubin, and white blood cell count were statistically different between never and prior smokers.
The odds ratio for each outcome in relation to smoking status was determined using logistic regression at baseline, after matching based on propensity scores, and further taking into account the unbalanced covariates (Table 4) . In unmatched analyses, current smokers were not more likely to have prolonged LOS compared with never smokers (1.1, 95% CI 1.0-1.3). Similarly, postoperative complications (1.1, 95% CI 0.9-1.2), 30-day return to OR (1.1, 95% CI 0.9-1.4), and 30-day mortality (1.1, 95% CI 0.8-1.6) rates were similar in current and in never smokers. This relationship persisted in matched analysis and after taking into account the unbalanced covariates. Prior smokers were not more likely to experience prolonged LOS (0.9, 95% CI 0.8-1.1), postoperative complications (1.0, 95% CI 0.8-1.2), 30-day return to OR (1.0, 95% CI 0.7-1.3), and 30-day mortality (1.0, 95% CI 0.6-1.7) compared with never smokers in unmatched analyses. After matching based on age and propensity scores, and with consideration of unbalanced covariates, prior smokers continued to have similar odds for poor outcomes compared with never smokers. The five most common CPT codes for all patients regardless of smok- † Comparing current smokers to never smokers after stratification based on propensity score and age. ‡ Comparing prior smokers to never smokers after stratification based on propensity score and age.
ing status were 61510, 61512, 61548, 61518, and 61885. We conducted sensitivity analyses limiting the sample size to include only patients with these CPT codes (4811 patients). We repeated all analyses using this limited sample, which produced the same results as in the full sample (data not shown). Table 5 demonstrates the number of smoking pack years. We examined the relationship between number of pack years and poor outcomes (Table 6) . Patients with a current or previous smoking history of 1-20 (0.7, 95% CI 0.6-0.9) and 21-40 (0.7, 95% CI 0.5-0.9) pack years were less likely to experience prolonged LOS compared with never smokers. However, patients who smoked > 60 pack years were more likely to experience prolonged LOS (1.3, 95% CI 1.1-1.6) and major complications (1.3, 95% 1.1-1.6) than nonsmokers. After matching based on propensity scores, current and prior smokers experienced similar outcomes to never smokers, regardless of the number of pack years (Table 7 ).
Discussion
We found that cigarette smoking was not associated with worse short-term (≤ 30 days) postoperative outcomes in patients who underwent elective cranial surgery. Current and prior smokers experienced similar outcomes when compared with never smokers. In unmatched analyses, current and prior history of smoking > 60 pack years was associated with increased odds of prolonged LOS and major complications. But in matched analyses, number of pack years of smoking was not associated with increased morbidity or mortality.
Although the impact of smoking on surgical outcomes has been studied in various specialties, this is the first multiinstitutional analysis of a prospectively collected set of data that examines the effect of smoking in a substantial number of patients undergoing elective cranial surgery. In the neurosurgical literature, the effects of smoking have been studied most extensively in the context of aneurysmal SAH. Cigarette smoking increases the risk for formation and growth of intracranial aneurysms. 11 Furthermore, in a prospective analysis of 75 consecutively admitted patients with aneurysmal SAH, Lasner and colleagues 14 found that smoking cigarettes was an independent risk factor for symptomatic vasospasm, although the authors controlled for only a limited number of variables. In a study of 453 patients undergoing craniotomy for tumor resection, Lau et al. 15 reported greater morbidity and 1-year mortality rates in smokers. However, it has * Odds ratios that are significant are written in boldface. † At baseline prior to stratification based on propensity scores. ‡ Propensity score consists of all factors reported as significant in Table 1 . § Unbalanced covariates after matching based on propensity score from Table 3 , including the following: alcohol consumption; BMI; pulmonary, cardiovascular, and CNS comorbidities; preoperative chemo-and/or radiotherapy; abnormal albumin, alkaline phosphatase, BUN, total bilirubin, and WBC count; and level of residency supervision in the OR. ¶ Unbalanced covariates after matching based on propensity score from Table 3 , including the following: transfer status; alcohol consumption; functional status; pulmonary comorbidities; disseminated cancer; abnormal albumin, alkaline phosphatase, BUN, and total bilirubin; and level of residency supervision in the OR. ** An LOS ≥ 8 days was considered to be prolonged. † † Having 1 or more minor or major complications. been suggested that in patients with lung cancer, in whom brain metastases are frequent, those who smoke may harbor a clinically more aggressive subtype of tumor, which may contribute to the worse outcome noticed in small series. 15, 17, 25 Smoking is often associated with other comorbidities. Thus, even if smoking itself does not exert an independent effect on postoperative outcomes, one might expect its associated comorbidities to influence the morbidity or mortality levels after major operations such as cranial surgery. The confounding effect of these variables must be controlled for. In unmatched analyses, we did not find an association between current or prior history of smoking and poor postoperative outcomes when compared with never smokers. This result is clarified when one notes that not all comorbidities were necessarily more common among current or prior smokers than in never smokers. For instance, in a comparison of current and never smokers, although pulmonary, cardiovascular, and CNS comorbidities were more common in current smokers, never smokers were older by an average of 4 years, had a slightly higher BMI, and were more likely to have hypertension or diabetes. The highly heterogeneous nature of smoking and nonsmoking patient populations further necessitates controlling for confounding variables. We matched patients based on propensity scores, and furthermore included unbalanced covariates to isolate the impact of smoking, as an independent risk factor, on surgical outcomes. In matched analyses, patients who were current or prior smokers did not have worse outcomes than patients who were never smokers. Using a similar methodological approach in a study of patients undergoing elective spine surgery, Seicean and colleagues 20 found that prior or current smokers do not experience worse outcomes than never smokers.
An alternative approach that can be used to match for confounding variables among smoking and nonsmoking patients has been proposed. Turan and colleagues 23 used NSQIP to examine the impact of smoking on perioperative outcomes in various surgical specialties. The authors * Odds ratios that are significant are written in boldface. † An LOS ≥ 8 days was considered to be prolonged. * Propensity score consists of all factors reported as significant in Table 1 . † An LOS ≥ 8 days was considered to be prolonged.
made a distinction between confounding variables such as age or sex, and causal variables such as chronic obstructive pulmonary disease, arguing that the potential impact of smoking on perioperative outcomes is mediated by the comorbidities it causes. Thus, these authors generated propensity scores based on confounding variables only. Turan et al. reported smoking to be predictive of an increased risk for poor postoperative outcomes, although they did not report specialty-specific outcome, and thus we are not aware of the specific outcomes in neurosurgical patients. We generated a propensity score that excluded cardiovascular, pulmonary, and CNS comorbidities, as suggested by Turan et al., and confirmed that prior and never smokers did not have higher odds for morbidity or mortality than never smokers (data not shown).
Clinical Implications
Even though smoking is not clearly associated with worse outcomes within 30 days after elective cranial surgery, the findings of this study are not intended to discourage smoking cessation. It is well established that smoking is a multiplier of risk for various morbidities and early mortality, and that smoking cessation is beneficial to patients' health and reduces health care costs. 16 Thus, smoking cessation should be encouraged, which might be particularly effective prior to surgery, 21 perhaps even earlier than in the time period included in NSQIP.
Limitations of the Study
This study has limitations. A retrospective analysis of multiinstitutional prospectively collected data, this study does not establish a cause and effect relationship between smoking and morbidity or mortality. We show here that patients with a current or prior history of smoking, compared with never smokers, do not experience worse outcomes. However, we did not examine the impact of smoking cessation in the study. The NSQIP database records smoking status within 1 year prior to surgery, which could potentially result in misclassification of patients who have ceased smoking; that is, true prior smokers could be classified as current smokers. Although the NSQIP gathers data from more than 450 academic and nonacademic institutions, the population captured in this database may not necessarily be representative of US patients who undergo elective cranial surgery. Nevertheless, data are collected prospectively for a large number of patients in a standardized fashion, and have been demonstrated repeatedly to be accurate and reproducible, 6, 12 allowing reliable analysis of the impact of smoking on perioperative outcomes in patients undergoing elective cranial surgery. It is important to note that the present analysis evaluated 30-day postoperative outcomes of elective cranial surgery; potential long-term deleterious effects of smoking beyond this period may exist, as outlined elsewhere. 2, 15, 24 
Conclusions
This is the first large, well-controlled study to evaluate the impact of preoperative smoking and the number of smoking pack years on 30-day postoperative outcomes based on data from a reliable national database of patients undergoing elective cranial surgery. Patients with a current or prior smoking history of > 60 pack years have more major complications and are more likely to have a prolonged LOS when compared with never smokers in unmatched analyses. In matched analyses, current or prior history of smoking, regardless of number of pack years, was not associated with diminished postoperative outcomes. Although smoking cessation is beneficial to patients' overall health, current or prior smoking may not compromise short-term perioperative outcomes in patients who undergo elective cranial surgery. Thus, a history of smoking may not be a concern for neurosurgeons and patients with regard to worse short-term outcomes of elective cranial surgery. Postponement of these cases for smoking cessation may not be warranted.
